OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Genomics
(1)
Repository
ENA
(1)
Release Date
2022
(5)
2023
(4)
2021
(4)
2020
(2)
2025
(1)
First Public Date
2025
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Role of meteorological parameters with the spread of Covid-19 in Pakistan: application of autoregressive distributed lag approach
Not available
S-EPMC10249560
|
biostudies-literature
Cite
Cost-effective fabrication, antibacterial application and cell viability studies of modified nonwoven cotton fabric.
Not available
S-EPMC8847346
|
biostudies-literature
Cite
Transcriptomic and metabolomic profiling reveal the close implication of alkaloid biosynthesis and ureide metabolism to drought stress tolerance in maize
PRJNA1245003
|
ENA
Cite
Biosynthesis of Polyhydroxyalkanoates (PHAs) by the Valorization of Biomass and Synthetic Waste.
Not available
S-EPMC7728366
|
biostudies-literature
Cite
Biallelic Variants in Seven Different Genes Associated with Clinically Suspected Bardet-Biedl Syndrome.
Not available
S-EPMC10217928
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets